Data shows strong overall survival, progression-free survival, and durability from novel combination of efti in combination with pembrolizumab in difficult-to-treat…
Precede Bio’s ER dependency index (PERDI) tests for both ER dependent and ER independent mechanisms of cancer growth, addressing an…
- IMM-1-104 has the potential to benefit melanoma patients who have progressed on or are intolerant to immune checkpoint inhibitors…
Webcast on December 17 at 8:00 AM EST to feature ALX Oncology leadership and study principal investigator Alberto J. Montero,…
Evaxion’s AI-Immunology™ platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical…
Company to Submit Product Development Plan to Treat External Squamous Cell Carcinoma (SCC) in HorsesToronto, Ontario and Philadelphia, Pennsylvania--(Newsfile Corp.…
NEW YORK, Dec. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global medical gas blenders…
NIH Initiatives Will Enhance Generative AI Usage and Health Data Discoverability RESTON, Va., Dec. 11, 2024 /PRNewswire/ -- ICF (NASDAQ:ICFI),…
Wearable technology developed leveraging the ISS National Lab aims to protect astronauts in deep space KENNEDY SPACE CENTER, Fla., Dec.…
CHAPEL HILL, N.C., Dec. 11, 2024 /PRNewswire/ -- Research spending at Carolina has topped $1.55 billion, fueling the state's economy,…